Antimicrobial chemotherapy booklet Flashcards
Bactericidal
An antimicrobial that kills bacteria (e.g. the penicillins)
Bacteriostatic
An antimicrobial that inhibits growth of bacteria (e.g. erythromycin)
Sensitive
An organism is considered sensitive if it is inhibited or killed by levels of the antimicrobial that are available at the site of infection.
Resistant
An organism is considered resistant if it is not killed or inhibited by levels of the antimicrobial that are available at the site of infection
Minimal inhibitory concentration (MIC)
minimum concentration of antimicrobial needed to inhibit visible growth of a given organism
Minimal bactericidal concentration (MBC)
minimum concentration of the antimicrobial needed to kill a given organism.
Routes of Administration:
Topical
Applied to a surface, usually skin or to mucous membranes e.g. conjunctiva.
Routes of Administration:
Systemic
Taken internally, either orally or parenterally.
Routes of Administration:
Parenteral
Administered either intra-venously (iv) or intra-muscularly (im), occassionally subcutaneously.
Sites of antibiotic action
- Inhibition of cell wall synthesis (eg, penicillins
& cephalosporins) - Inhibition of protein synthesis (eg, gentamicin
& erythromycin) - Inhibition of nucleic acid synthesis (eg, trimethoprim & ciprofloxacin)
gentamicin & erythromycin inhibit
protein synthesis
penicillins & cephalosporins inhibit
cell wall synthesis
- also known as b-lactams
trimethoprim & ciprofloxacin inhibit
nucleic acid synthesis
β-lactam antibiotics disrupt
peptidoglycan synthesis by inhibiting the enzymes which are responsible for cross-linking the carbohydrate chains.
human cells are not effected by antibiotics that
inhibit cell wall synthesis as human cells do not have cell walls.
Benzyl penicillin was
original naturally occurring β-lactam discovered by Fleming
Penicillins and cephalosporins are the two groups of
b-lactam antibiotics
b-lactams inhibit
cell wall synthesis
Vancomycin and teicoplanin are the two
glycopeptide antibiotics in common clinical usage.
Vancomycin and teicoplanin both act on
cell wall synthesis at a stage prior to β-lactams, inhibiting assembly of a peptidoglycan precursor.
- act only on gram positive organisms
penicillin-binding proteins (PBPs)
enzymes involved in the synthesis of Peptidoglycan.
Vancomycin and teicoplanin are not absorbed
from the GI tract and are only given parenterally, except in special circumstances.
common problem with vancomycin
Toxicity
- intravenous infusion must be given carefully to avoid local tissue damage if it leaks from the veins
- should be infused slowly over a period of hours
vancomycin side effects
ototoxicity - affects ears
nephrotoxicity - affects kidney
skin rashes
Protein synthesis involves
translation of messenger RNA at the ribosome.
Differences between the bacterial ribosome and the mammalian ribosome allow selective action on bacterial protein synthesis.
Aminoglycosides example
gentamicin
Aminoglycosides (e.g. gentamicin) are especially useful in
the treatment of serious Gram negative (e.g. coliform) infection.
primary use of aminoglycosides is to
treat gram negative infection and they are injectable rather than oral antibiotics.
problem with gentamicin
toxic and requires a careful dosing regime (follow local guidelines) and monitoring of levels.
antibiotics which act on protein synthesis
- Aminoglycosides
- macrolides
- tetracyclines
- Oxazolidinones
- Cyclic Lipopeptide
macrolides example
erythromycin
clarithromycin
Macrolide antibiotics are useful alternatives
to penicillins in treatment of gram positive infections in patients who are penicillin allergic
new class of protein synthesis inhibitors in common use
Linezolid
- has good activity against MRSA and can be given orally
Linezolid is generally held in reserve for
the treatment of serious infection. eg MRSA
Cyclic Lipopeptide example
Daptomycin
Oxazolidinones example
Linezolid
Daptomycin used against
Gram positives in general
- MRSA in particular
At present it is used in serious infections on specialist advice.
A wide range of antibiotics inhibit DNA synthesis
either directly, or indirectly by interrupting the supply of precursors for DNA synthesis.
Inhibitors of nucleic acid synthesis
- Trimethoprim and sulphamethoxazole
- Fluoroquinolones
Trimethoprim and sulphamethoxazole inhibit
different steps in purine synthesis, and are used in a combined form in the drug co-trimoxazole.
Trimethoprim is also used for
- chest infections
- urinary tract infections
Fluoroquinolones example
- ciprofloxacin
- levofloxacin
Ciprofloxacin is effective against
Gram negative organisms and can be taken orally and parenterally.
Ciprofloxacin cannot be used in
children as it could interfere with cartilage growth.
levofloxacin has more activity against
gram positive bacteria
sometimes used for chest infections
Types of Resistance:
- Inherent or intrinsic resistance
- Acquired resistance
Acquired resistance
may be present in some strain species but not in others.
this can happen through:
- spontaneous mutation
- genes coding for resistance may be passed on from organism to organism or species to species. (more common)
widespread use of antibiotics causes
selective pressure and encourages new resistant organisms to outgrow sensitive strains.
plasmids
extra chromosomal packages of DNA
transposons
packets of DNA which insert themselves into the chromosome
genes that have acquired resistance can be carried in
- transposons
- plasmids
Resistance to b–lactam antibiotics
two mechanisms:
- b-lactamase production
- Alteration of penicillin binding protein (PBP) target site
b−lactamases are
bacterial enzymes which cleave the b–lactam ring of the antibiotic and thus render it inactive.
ways to combat β-lactamase
- introduce a second component to the antibiotic which is a b-lactamase inhibitor and therefore protects the antibiotic from enzymic degradation
- modify the antibiotic side chain to produce an antibiotic which is resistant to the actions of b-lactamase
b-lactamase inhibitor example
clavulanic acid (in co-amoxiclav, antibiotic is amoxicillin)
Flucloxacillin is
b-lactamase resistant, and can be used to treat b-lactamase producing Staph. aureus.
Some organisms (eg, MRSA) have
genetically altered target sites (PBPs) to which b-lactams cannot bind.
MRSA are resistant to
all penicillins and cephalosporins.
ESBLs (extended spectrum β-lactamases) are
produced by some gram negative organisms and render them resistant to all β-lactam agents.
Vancomycin resistance is unusual in
Gram positive organisms.
Vancomycin resistant enterococci (VREs) have
appeared recently.
- the peptidoglycan precursor to which vancomycin normally binds has an altered structure - example of an altered target site